We are live on
!
Find out more
DIM
DC Investments Management Portfolio holdings
AUM
$261M
1-Year Est. Return
20.71%
This Fund
S&P 500
This Quarter
Est. Return
+3.69%
1 Year Est. Return
+20.71%
3 Year Est. Return
+44.71%
5 Year Est. Return
+36.74%
10 Year Est. Return
–
AUM
$157M
AUM Growth
+$8.18M
(+5.5%)
Cap. Flow
+$6.12M
Cap. Flow
% of AUM
3.89%
Top 10 Holdings %
Top 10 Hldgs %
6.71%
Holding
424
New
174
Increased
42
Reduced
68
Closed
139
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Evergy
EVRG
|
+$1.09M |
| 2 |
AerCap
AER
|
+$863K |
| 3 |
GRMN
Garmin
GRMN
|
+$838K |
| 4 |
GSK
GSK
|
+$820K |
| 5 |
SF
Stifel
SF
|
+$818K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.51M |
| 2 |
Amgen
AMGN
|
+$2.11M |
| 3 |
Johnson & Johnson
JNJ
|
+$1.68M |
| 4 |
Northrop Grumman
NOC
|
+$1.55M |
| 5 |
Becton Dickinson
BDX
|
+$1.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.87% |
| 2 | Financials | 19.67% |
| 3 | Technology | 12.25% |
| 4 | Real Estate | 10.82% |
| 5 | Utilities | 10.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Motorola Solutions
MSI
$73.4B
| $583K | 0.37% |
5,008
-511
| -9% | -$56.3K |
|
|
CYS
77
DELISTED
CYS Investments Inc.
CYS
| $580K | 0.37% |
77,276
+31,596
| +69% | +$226K |
|
78
Exelon
EXC
$47.1B
| $579K | 0.37% |
+19,062
| New | +$546K |
|
79
Fidelity National Information Services
FIS
$22.4B
| $578K | 0.37% |
5,448
-11,319
| -68% | -$1.15M |
|
80
ExxonMobil
XOM
$633B
| $578K | 0.37% |
6,985
+2,499
| +56% | +$199K |
|
81
Labcorp
LH
$25.4B
| $577K | 0.37% |
3,742
+77
| +2% | +$11.6K |
|
|
WRI
82
DELISTED
Weingarten Realty Investors
WRI
| $577K | 0.37% |
+18,738
| New | +$535K |
|
83
Jack Henry & Associates
JKHY
$11.1B
| $576K | 0.37% |
4,418
-1,603
| -27% | -$199K |
|
84
OGE Energy
OGE
$9.69B
| $576K | 0.37% |
16,366
-12,267
| -43% | -$412K |
|
85
Brown & Brown
BRO
$23.9B
| $575K | 0.37% |
20,734
+6,066
| +41% | +$165K |
|
86
Neuronetics
STIM
$161M
| $575K | 0.37% |
+21,598
| New | +$587K |
|
87
National Health Investors
NHI
$3.62B
| $572K | 0.36% |
+7,770
| New | +$549K |
|
88
Sonoco
SON
$5.79B
| $572K | 0.36% |
+10,896
| New | +$560K |
|
89
AT&T
T
$156B
| $572K | 0.36% |
+23,578
| New | +$592K |
|
90
Western Union
WU
$2.29B
| $569K | 0.36% |
+27,978
| New | +$557K |
|
|
RPAI
91
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $569K | 0.36% |
+44,538
| New | +$533K |
|
|
HOLX
92
DELISTED
Hologic
HOLX
| $568K | 0.36% |
+14,292
| New | +$550K |
|
|
CVG
93
DELISTED
Convergys
CVG
| $568K | 0.36% |
+23,232
| New | +$554K |
|
|
ALE
94
DELISTED
Allete
ALE
| $566K | 0.36% |
7,313
+2,289
| +46% | +$171K |
|
95
Rithm Capital
RITM
$5.7B
| $566K | 0.36% |
+32,370
| New | +$568K |
|
96
Merck
MRK
$322B
| $565K | 0.36% |
9,753
-1,071
| -10% | -$60.4K |
|
97
Public Service Enterprise Group
PEG
$37.7B
| $565K | 0.36% |
10,434
-3,750
| -26% | -$193K |
|
98
Broadridge
BR
$19.1B
| $563K | 0.36% |
4,888
-809
| -14% | -$91.3K |
|
99
Stryker
SYK
$130B
| $563K | 0.36% |
3,333
-5,885
| -64% | -$990K |
|
100
Xeris Biopharma Holdings
XERS
$1.43B
| $563K | 0.36% |
+29,674
| New | +$577K |
|
Similar funds
DC
AFC
TIG
NG
ICM
TSW
ACM
ASP
DC Investments Management's Q2 2018 Portfolio in Review
As of Q2 2018, DC Investments Management held 424 positions worth $157M, up 5.5% from $149M the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
DC Investments Management deployed $6.12M of net new capital in Q2 2018, opening 174 new positions and adding to 42 existing holdings. Its largest new stake was Evergy: 20,319 shares worth $1.14M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 23% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Pfizer, an estimated $2.51M trimmed.
- DC Investments Management's largest Q2 2018 buy was Evergy: 20,319 shares worth $1.14M.
- DC Investments Management added most to TotalEnergies in Q2 2018, an estimated $612K increase.
- DC Investments Management's biggest Q2 2018 reduction was Pfizer, cutting an estimated $2.51M.
- DC Investments Management fully exited Amgen in Q2 2018, selling an estimated $2.11M.
- DC Investments Management's ten largest holdings make up 6.7% of its $157M portfolio in Q2 2018.
- DC Investments Management opened 174 new positions and closed 139 in Q2 2018.
- DC Investments Management's portfolio value rose 5.5% quarter-over-quarter to $157M.
Based on DC Investments Management's 13F filing for Q2 2018, filed 3 Aug 2018.